🔥🐔 BizChicken 🐔🔥
Companies Similar to Corbus Pharmaceuticals Holdings, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CNS Pharmaceuticals, Inc.
Berubicin
CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company focused on developing anti-cancer drugs for brain and central nervous system tumors. Their lead drug candidate, Berubicin, targets glioblastoma multiforme through clinical trials and partnerships with notable institutions.
Symbol: CNSP
Recent Price: $0.11
Industry: Biotechnology
CEO: Mr. John Michael Climaco Esq., J.D.
Sector: Healthcare
Employees: 3
Address: 2100 West Loop South, Houston, TX 77027
Phone: 800 946 9185
Last updated: 2024-12-31
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Celldex Therapeutics, Inc.
therapeutic monoclonal and bispecific antibodies
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.
About | About | Management | Directors | About | Contact | About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About
Symbol: CLDX
Recent Price: $25.12
Industry: Biotechnology
CEO: Mr. Anthony S. Marucci M.B.A.
Sector: Healthcare
Employees: 160
Address: Perryville III Building, Hampton, NJ 08827
Phone: 908 200 7500
Leadership
- Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
- Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
- Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
- Sam Martin, Senior Vice President and Chief Financial Officer
- Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
- Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
- Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
- Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
- Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
- Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
- Keith L. Brownlie, Former Partner, Ernst & Young LLP
- Herbert J. Conrad, Former President, Roche Pharmaceuticals US
- James J. Marino, J.D., Former Partner, Dechert LLP
- Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
- Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
- Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
- Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
- Carl June, M.D.,
- Michel Nussenzweig, M.D., Ph.D.,
- Marc E. Rothenberg M.D., Ph.D.,
- Joseph Schlessinger, Ph.D.,
- Louis Weiner, M.D.,
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Chimerix, Inc.
TEMBEXA (brincidofovir)
Chimerix, Inc. is a biopharmaceutical company that develops medicines to enhance the lives of patients with serious diseases, including smallpox and various tumors.
Leadership | Contact | Contact | Careers | Jobs | Jobs | About | Leadership
Symbol: CMRX
Recent Price: $3.44
Industry: Biotechnology
CEO: Mr. Michael T. Andriole M.B.A.
Sector: Healthcare
Employees: 72
Address: 2505 Meridian Parkway, Durham, NC 27713
Phone: 919 806 1074
Leadership
- Mike Andriole, President, CEO
- Joshua E. Allen, PhD, Chief Scientific Officer
- Michael A. Alrutz, JD, PhD, Senior Vice President and General Counsel
- Michelle LaSpaluto, Chief Financial Officer
- Allen Melemed, MD, MBA, Chief Medical Officer
- Tom Riga, Chief Operating and Commercial Officer
- Roy W. Ware, PhD, MBA, Chief Manufacturing Technology Officer
- Caryn Barnett, Vice President Clinical Operations
- Tom Brundage, Vice President Biostatistics
- David Jakeman, VP Accounting and Finance
- Christopher Jordan, Vice President Regulatory Affairs
- Pablo Lee, Vice President Medical Affairs
- Odin Naderer, PharmD, Vice President Clinical Pharmacology and Translational Medicine
- Mike Sherman, Chairman
- Martha J. Demski, Lead Independent Director
- Lisa Decker, PhD,
- Marc D. Kozin,
- Robert J. Meyer, MD,
- Fred A. Middleton,
- Pratik S. Multani, MD,
- Vicki Vakiener,
Last updated: 2024-12-31
Corbus Pharmaceuticals Holdings, Inc.
lenabasum, CRB-601, CRB-602
Corbus Pharmaceuticals Holdings, Inc., is a biopharmaceutical company focused on immune modulators for immuno-oncology and fibrosis diseases, developing products like lenabasum and monoclonal antibodies for cancer and fibrosis.
About | Leadership | About | About | Contact | About | Contact | Contact | About | About | About
Symbol: CRBP
Recent Price: $12.08
Industry: Biotechnology
CEO: Dr. Yuval Cohen Ph.D.
Sector: Healthcare
Employees: 19
Address: 500 River Ridge Drive, Norwood, MA 02062
Phone: 617 963 0100
Leadership
- Alan Holmer, Chairman of the Board
- Yuval Cohen, Ph.D., Chief Executive Officer, Director
- Anne Altmeyer, Ph.D., Director
- Yong Ben, M.D., MBA, Director
- Rachelle Jacques, Director
- John Jenkins, M.D., Director
- Pete Salzmann, M.D., MBA, Director
- Winston Kung, MBA, Director
- Dr. Dominic Smethurst, MA MRCP, Chief Medical Officer
- Sean Moran, CPA, MBA, Chief Financial Officer
- Christina Bertsch, VP of Human Resources
- Dr. Dominic Smethurst, Chief Medical Officer
Last updated: 2024-12-31
Curis, Inc.
Emavusertib
Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.
About | Management | Directors | About | About | Contact | Contact | Contact | About | Careers | Careers | Benefits | About | About | About | About | Jobs | About
Symbol: CRIS
Recent Price: $3.14
Industry: Biotechnology
CEO: Mr. James E. Dentzer
Sector: Healthcare
Employees: 49
Address: Building C, Lexington, MA 02421
Phone: 617 503 6500
Leadership
- Martyn D. Greenacre, Chair of the Board
- John Hohneker, M.D., Director
- Kenneth I. Kaitin, Ph.D., Director
- Anne E. Borgman, M.D., Director
- Marc Rubin, M.D., Director
- James Dentzer, Chief Executive Officer and Director
Last updated: 2024-12-31
Corvus Pharmaceuticals, Inc.
Mupadolimab (CPI-006)
Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing immuno-oncology therapies, including Mupadolimab for non-small cell lung cancer, CPI-818 for T-cell lymphomas, and Ciforadenant for renal cell cancer.
Symbol: CRVS
Recent Price: $5.25
Industry: Biotechnology
CEO: Dr. Richard A. Miller M.D.
Sector: Healthcare
Employees: 28
Address: 863 Mitten Road, Burlingame, CA 94010
Phone: 650 900 4520
Last updated: 2024-12-31
Cue Biopharma, Inc.
CUE-101
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing biologic drugs to modulate the human immune system for treating cancers, chronic infectious diseases, and autoimmune disorders.
About | Leadership | About | Directors | About | Contact | About | About | About | Careers | Careers | Careers | Careers | Careers | About
Symbol: CUE
Recent Price: $1.02
Industry: Biotechnology
CEO: Mr. Daniel R. Passeri J.D., M.Sc.
Sector: Healthcare
Employees: 53
Address: 21 Erie Street, Cambridge, MA 02139
Phone: 617 949 2680
Leadership
- Dan Passeri, Chief Executive Officer
- Anish Suri, President and Chief Scientific Officer
- Lucinda Warren, Chief Business Officer
- Matteo Levisetti, Chief Medical Officer
- Kerri-Ann Millar, Chief Financial Officer
- Colin Sandercock, Senior Vice President and General Counsel
- Frank Morich, M.D., Ph.D., Chairman of the Board
- Dan Passeri, M.Sc., J.D., Chief Executive Officer
- Peter Kiener, D.Phil.,
- Fred Driscoll,
- Patrick Verheyen,
- Pamela D. Garzone, Ph.D.,
Last updated: 2024-12-31
Eloxx Pharmaceuticals, Inc.
ELX-02
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.
Symbol: ELOX
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Sector: Healthcare
Employees: 18
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 781 577 5300
Last updated: 2024-12-31
Immuneering Corporation
IMM-1-104 and IMM-6-415
Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.
Symbol: IMRX
Recent Price: $2.25
Industry: Biotechnology
CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Sector: Healthcare
Employees: 66
Address: 245 Main Street, Cambridge, MA 02142
Phone: 617 500 8080
Last updated: 2024-12-31
Korro Bio, Inc.
genetic medicines based on editing RNA
Korro Bio, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing genetic medicines based on RNA editing to treat rare and widespread diseases. The company is based in Cambridge, Massachusetts and aims to provide clinical benefits through their innovative approach.
Symbol: KRRO
Recent Price: $38.11
Industry: Biotechnology
CEO: Mr. Ram Aiyar MBA, Ph.D.
Sector: Healthcare
Employees: 92
Address: One Kendall Square, Cambridge, MA 02139-1562
Phone: 781-315-4600
Last updated: 2024-12-31
Syros Pharmaceuticals, Inc.
Tamibarotene
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.
About | Leadership | Directors | About | Contact | Careers | Vision/Values | DEI | Careers | About | About
Symbol: SYRS
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Conley Chee
Sector: Healthcare
Employees: 68
Address: 35 CambridgePark Drive, Cambridge, MA 02140
Phone: 617 744 1340
Leadership
- Conley Chee, President and Chief Executive Officer
- Jason Haas, Chief Financial Officer
- Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
- Lisa Roberts, VP Human Resources
- David A. Roth, M.D., Chief Medical Officer
- Kristin Stephens, Chief Development Officer
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Arbutus Biopharma Corporation
AB-729, AB-836, AB-161, AB-101
Arbutus Biopharma Corporation is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. The company's HBV product pipeline includes RNA interference products and oral capsid inhibitors, and it is involved in strategic alliances for research and development.
About | Leadership | Directors | Contact | Contact | Culture | Jobs | Culture | About | About
Symbol: ABUS
Recent Price: $3.20
Industry: Biotechnology
CEO: Mr. Michael J. McElhaugh
Sector: Healthcare
Employees: 73
Address: 701 Veterans Circle, Warminster, PA 18974
Phone: 267 469 0914
Leadership
- Michael J. McElhaugh, Interim President and Chief Executive Officer and Director
- Michael J. Sofia PhD, Chief Scientific Officer
- Karen Sims, MD, PhD, Chief Medical Officer
- David C. Hastings, Chief Financial Officer
- Christopher Naftzger, General Counsel and Chief Compliance Officer
- Lisa Caperelli, Vice President, Investor Relations
- Shannon Briscoe, SPHR, SHRM-SCP, Vice President, Human Resources
- Frank Torti, MD, Chairman
- Daniel Burgess, Independent Director
- Richard C. Henriques, Independent Director
- Keith Manchester, MD, Independent Director
- James Meyers, Independent Director
- Melissa V. Rewolinski, PhD, Independent Director
Last updated: 2024-12-31
Adaptive Biotechnologies Corporation
immunoSEQ
Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.
Leadership | Contact | About | About | About | About | Careers | Careers | About | About | About | About | About
Symbol: ADPT
Recent Price: $6.11
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A.
Sector: Healthcare
Employees: 709
Address: 1165 Eastlake Avenue East, Seattle, WA 98109
Phone: 206 659 0067
Last updated: 2024-12-31
Creative Medical Technology Holdings, Inc.
Imm Celz
Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.
Symbol: CELZ
Recent Price: $2.34
Industry: Biotechnology
CEO: Mr. Timothy Warbington
Sector: Healthcare
Employees: 4
Address: 211 East Osborn Road, Phoenix, AZ 85012
Phone: 480 399 2822
Last updated: 2024-12-31